Cited 54 times in
The effect of botulinum toxin type A injection for intrinsic rhinitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김경수 | - |
dc.contributor.author | 윤주헌 | - |
dc.date.accessioned | 2020-07-02T17:47:20Z | - |
dc.date.available | 2020-07-02T17:47:20Z | - |
dc.date.issued | 1998 | - |
dc.identifier.issn | 0022-2151 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/177041 | - |
dc.description.abstract | Botulinum toxin type A (BTA) is known to inhibit the release of acetylcholine from cholinergic nerve endings. Owing to the characteristics of BTA, we thought that it could be used for the treatment of intrinsic rhinitis acting as an anticholinergic drug. In a double-blind placebo-controlled study four units of BTA were injected into the middle turbinate (two units) and inferior turbinate (two units) in each nasal cavity. Rhinorrhoea, nasal obstruction, and sneezing were recorded in a symptom diary on the basis of a scale of 5 and the number of paper tissues used per day was also recorded for 24 weeks. Rhinorrhoea was significantly diminished in severity (24.1-41.5 per cent reduction) and paper tissue use (54.3 per cent reduction) in the BTA group compared with the placebo group. This effect could be maintained for four weeks. Sneezing and nasal stuffiness were not affected by BTA. These results suggest that BTA can be used to treat rhinorrhoea in intrinsic rhinitis patients, however, the effective period is short. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Cambridge University Press | - |
dc.relation.isPartOf | JOURNAL OF LARYNGOLOGY AND OTOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Botulinum Toxins, Type A/administration & dosage | - |
dc.subject.MESH | Botulinum Toxins, Type A/therapeutic use* | - |
dc.subject.MESH | Cholinergic Antagonists/therapeutic use* | - |
dc.subject.MESH | Double-Blind Method | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Injections | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Nasal Septum | - |
dc.subject.MESH | Rhinitis/drug therapy* | - |
dc.subject.MESH | Statistics, Nonparametric | - |
dc.title | The effect of botulinum toxin type A injection for intrinsic rhinitis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Otorhinolaryngology (이비인후과학교실) | - |
dc.contributor.googleauthor | Kyung-Su Kim | - |
dc.contributor.googleauthor | Sung-Shik Kim | - |
dc.contributor.googleauthor | Joo-Heon Yoon | - |
dc.contributor.googleauthor | Jae Wook Han | - |
dc.identifier.doi | 10.1017/s0022215100158281 | - |
dc.contributor.localId | A00298 | - |
dc.contributor.localId | A02604 | - |
dc.relation.journalcode | J01557 | - |
dc.identifier.eissn | 1748-5460 | - |
dc.identifier.pmid | 9624373 | - |
dc.identifier.url | https://www.cambridge.org/core/journals/journal-of-laryngology-and-otology/article/effect-of-botulinum-toxin-type-a-injection-for-intrinsic-rhinitis/9859EBCEC4F92E5328AF6AC198F8A9B7 | - |
dc.contributor.alternativeName | Kim, Kyung Su | - |
dc.contributor.affiliatedAuthor | 김경수 | - |
dc.contributor.affiliatedAuthor | 윤주헌 | - |
dc.citation.volume | 112 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 248 | - |
dc.citation.endPage | 251 | - |
dc.identifier.bibliographicCitation | JOURNAL OF LARYNGOLOGY AND OTOLOGY, Vol.112(3) : 248-251, 1998 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.